Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Jonas Grumby who wrote (668)	6/30/1998 2:21:00 PM
From: Peter Singleton	Read Replies (2) \| Respond to of 1510

Folks, I agree with you guys that the news should be great later this week, and there's a chance for institutional buying plus retail, especially if there's a popular press article like the WSJ article on Sustiva today. But, what do you think are the chances of a sell-off on the news? The expectation that Valentine will present significant results has gotten a lot of airplay, and the stock has run from 11 to 15 (with a spike to 19). I've bought IMNR + IMNR calls + AGPH calls, so obviously I think the news will be material, and have long-lasting implications for the value of both stocks ... but I recognize there's a chance that the market has already absorbed the news. My best guess is that it hasn't, and there will be some run in the stock(s), but that's just a guess. What do you guys think? Peter